Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?
Article
Geissler, Edward K., Schnitzbauer, Andreas A. and Schlitt, Hans J. (2016) Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story? Liver Transplantation 22 (8), pp. 1162-1163.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Liver Transplantation | ||||
| Publisher | WILEY-BLACKWELL | ||||
| Place of Publication | HOBOKEN | ||||
| Volume | 22 | ||||
| Number of Issue or Book Chapter | 8 | ||||
| Page Range | pp. 1162-1163 | ||||
| Date | 2016 | ||||
| Date of publication | 17 Mar 2020 11:33 | ||||
| Institutions | Medicine > Lehrstuhl für Chirurgie | ||||
| Identification Number |
| ||||
| Keywords | ; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 42546 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric